Markets:

Overview

News

Currencies

International

Treasuries

Cardinal Health (NY:CAH)

227.96 +3.71 (+1.65%)

Streaming Delayed Price Updated: 10:56 AM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Battleground Stocks: 3 Heavily Shorted Meme Stocks to Watch ↗

February 14, 2023

Heavily shorted meme stocks are often considered high-risk investments due to their volatility and potential for rapid gains or losses.

Via InvestorPlace

Palantir Q4 Earnings Preview: Will The Data Software Company Deliver On CEO Expectations For A 'Strong Finish To The Year'? ↗

February 13, 2023

Palantir Technologies Inc (NYSE: PLTR) is set to report fourth-quarter earnings results after the bell. The stock is up approximately 18% since the start of the year, but it's still down more than 40%...

Via Benzinga

Why Palantir, Twilio, and HubSpot Each Surged Over 20% in January ↗

February 07, 2023

Beaten-down enterprise software stocks got a relief rally in January. But will the good times last?

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 ↗

February 03, 2023

Via Benzinga

Cardinal Health's Earnings Outlook ↗

February 01, 2023

Via Benzinga

Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line? ↗

February 02, 2023

The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging.

Via Benzinga

7 Analysts Have This to Say About Cardinal Health ↗

January 31, 2023

Via Benzinga

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products

January 17, 2023

By David Willey, Benzinga

Via TheNewswire.com

Topics Economy

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products

January 17, 2023

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products

Via News Direct

Topics Economy

The Latest Analyst Ratings for Cardinal Health ↗

January 06, 2023

Via Benzinga

6 Analysts Have This to Say About Cardinal Health ↗

November 22, 2022

Via Benzinga

Analyst Ratings for Cardinal Health ↗

November 04, 2022

Cardinal Health (NYSE:CAH) has observed the following analyst ratings within the last quarter:

Via Benzinga

Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch ↗

January 29, 2023

With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed.

Via Benzinga

Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products ↗

January 17, 2023

Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the...

Via Benzinga

Recap: Cardinal Health Q1 Earnings ↗

November 04, 2022

Cardinal Health (NYSE:CAH) reported its Q1 earnings results on Friday, November 4, 2022 at 06:55 AM. Here's what investors need to know about the announcement.

Via Benzinga

Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029

January 12, 2023

EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END

Via FinancialNewsMedia

Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry ↗

January 09, 2023

Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development...

Via Benzinga

Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash ↗

January 07, 2023

If the tide runs out, you won't be caught swimming naked with these two stocks in your portfolio.

Via The Motley Fool

2 Dividend Aristocrat Stocks To Buy And Never Sell ↗

January 06, 2023

A dividend aristocrat is a stock that is a member of the S&P500 that has raised dividend payments for at least 25 consecutive years. This filter alone is an effective way to identify companies with...

Via Talk Markets

5 Stocks In S&P 500 ETF With 40% Gains In 2022 ↗

January 03, 2023

Despite the decline, some of the stocks in SPY’s portfolio have risen more than 40%.

Via Talk Markets

The 8 Dividend Aristocrats With The Smallest Dividend Increases ↗

January 01, 2023

Dividend Aristocrats comprise an elite group of 65 S&P 500 stocks with 25+ years of consecutive dividend increases. These stocks are celebrated amongst dividend growth investors and are considered...

Via Talk Markets

Buy This Warren Buffett-Owned Stock for 2023 and Beyond ↗

December 26, 2022

This healthcare products distributor's business model can withstand a recession.

Via The Motley Fool

2 Healthcare Stocks You Can Buy and Hold for the Next Decade ↗

December 24, 2022

These companies are safe havens during tough times, with above-average dividends.

Via The Motley Fool

Got $5,000? These 2 Dividend Stocks Are Yielding More Than 2% ↗

December 22, 2022

These companies likely aren't done raising their dividend payments anytime soon.

Via The Motley Fool

20 Dividend Growth Stocks For Faster Growth And Profit ↗

December 15, 2022

The equal weight growth model was willing to accept faster-growing companies with lower current dividend yields, but faster-growing dividends.

Via Talk Markets

Finding 20 Dividend Growth Stocks In A Bad Market ↗

December 14, 2022

Starting in 2012, it became more and more difficult for prudent dividend growth stock investors looking for income. The stock market was trading at excessive valuations, and interest rates were at...

Via Talk Markets

Dividend Income Update October 2022 ↗

November 17, 2022

It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio.

Via Talk Markets

US Authority Plans Massive Expansion Of Medication Access To Combat Opioid Overdose Crisis ↗

November 08, 2022

Struggling with the opioid crisis, U.S. authorities plan to substantially expand access to medications tackling opioid addiction, such as methadone, buprenorphine, and naltrexone.

Via Benzinga

Cardinal Health's Return On Capital Employed Insights ↗

November 07, 2022

Pulled from Benzinga Pro data, Cardinal Health (NYSE:CAH) showed a loss in earnings since Q4, totaling $111.00 million. Sales, on the other hand, increased by 5.31% to $49.60 billion during Q1.

Via Benzinga

Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review ↗

November 04, 2022

A mixed jobs report and heavy earnings swung stocks.

Via Investor's Business Daily

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cardinal Health (NY:CAH)

All News about Cardinal Health

Starting at $3.75/week.

Subscribe Today